Jiangsu Aidea Pharmaceutical Group Co., Ltd.

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Single Ascending Dose Study of ACC085 Injection in Healthy Chinese Adults	Healthy Adult Participants	Recruiting	Phase 1	2026-09-25	NCT07835633
Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection	Healthy Adult Participants	Recruiting	Phase 1	2026-08-05	NCT07729839
Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1)	AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease	Recruiting	Phase 1 / Phase 2	2026-07-17	NCT07711223
Efficacy and Safety of the ACC017-Based Antiretroviral Regimen in Treatment-Experienced Adults With HIV-1 Harboring Non-Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations	AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease	Active, not recruiting	Phase 1 / Phase 2	2026-07-17	NCT07711210

Clinical trials